108 related articles for article (PubMed ID: 213554)
1. Clonidine and related imidazolines are postsynaptic alpha adrenergic antagonists in dispersed rat parotid cells.
Davis JN; Maury W
J Pharmacol Exp Ther; 1978 Nov; 207(2):425-30. PubMed ID: 213554
[TBL] [Abstract][Full Text] [Related]
2. Receptor interactions of imidazolines. V. clonidine differentiates postsynaptic alpha adrenergic receptor subtypes in tissues from the rat.
Ruffolo RR; Yaden EL; Waddell JE
J Pharmacol Exp Ther; 1980 Jun; 213(3):557-61. PubMed ID: 6259319
[TBL] [Abstract][Full Text] [Related]
3. K+ release from rat parotid cells: an alpha 1-adrenergic mediated event.
Ito H; Hoopes MT; Baum BJ; Roth GS
Biochem Pharmacol; 1982 Feb; 31(4):567-73. PubMed ID: 6279109
[TBL] [Abstract][Full Text] [Related]
4. alpha-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium efflux.
Strittmatter WJ; Davis JN; Lefkowitz RJ
J Biol Chem; 1977 Aug; 252(15):5472-7. PubMed ID: 195950
[No Abstract] [Full Text] [Related]
5. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
[TBL] [Abstract][Full Text] [Related]
6. Denervation-induced changes in alpha and beta adrenergic receptors of the rat submandibular gland.
Arnett CD; Davis JN
J Pharmacol Exp Ther; 1979 Nov; 211(2):394-400. PubMed ID: 228025
[TBL] [Abstract][Full Text] [Related]
7. Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists.
Ruffolo RR; Waddell JE
Br J Pharmacol; 1982 Sep; 77(1):169-76. PubMed ID: 6289955
[TBL] [Abstract][Full Text] [Related]
8. alpha-Adrenergic receptors in rat parotid cells. II. Desensitization of receptor binding sites and potassium release.
Strittmatter WJ; Davis JN; Lefkowitz RJ
J Biol Chem; 1977 Aug; 252(15):5478-82. PubMed ID: 195951
[No Abstract] [Full Text] [Related]
9. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activities.
de Jonge A; Timmermans PB; van Zwieten PA
J Pharmacol Exp Ther; 1982 Sep; 222(3):705-11. PubMed ID: 6125586
[No Abstract] [Full Text] [Related]
10. Relation between central sympathoinhibitory and peripheral pre- and postsynaptic alpha-adrenoceptors as evaluated by different clonidine-like substances in rats.
Kobinger W; Pichler L
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):21-7. PubMed ID: 6113548
[TBL] [Abstract][Full Text] [Related]
11. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activities.
de Jonge A; Timmermans PB; van Zwieten PA
J Pharmacol Exp Ther; 1982 Sep; 222(3):712-9. PubMed ID: 6125587
[No Abstract] [Full Text] [Related]
12. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
Taouis M; Berlan M; Lafontan M
Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
[TBL] [Abstract][Full Text] [Related]
14. Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.
Greney H; Ronde P; Magnier C; Maranca F; Rascente C; Quaglia W; Giannella M; Pigini M; Brasili L; Lugnier C; Bousquet P; Dontenwill M
Mol Pharmacol; 2000 Jun; 57(6):1142-51. PubMed ID: 10825384
[TBL] [Abstract][Full Text] [Related]
15. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects.
Huerta-Bahena J; Villalobos-Molina R; García-Sáinz JA
Mol Pharmacol; 1983 Jan; 23(1):67-70. PubMed ID: 6135146
[TBL] [Abstract][Full Text] [Related]
16. Potassium release by alpha 2-adrenergic receptor stimulation of rat parotid acinar cells.
Miller GD; Davis JN
Biochem Pharmacol; 1982 Jun; 31(12):2197-9. PubMed ID: 6126196
[TBL] [Abstract][Full Text] [Related]
17. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
Nakaki T; Nakadate T; Yamamoto S; Kato R
J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
[TBL] [Abstract][Full Text] [Related]
18. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
Nasseri A; Minneman KP
Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
[TBL] [Abstract][Full Text] [Related]
19. Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
Uchida T; Ito H; Baum BJ; Roth GS; Filburn CR; Sacktor B
Mol Pharmacol; 1982 Jan; 21(1):128-32. PubMed ID: 6127617
[TBL] [Abstract][Full Text] [Related]
20. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
Takano Y; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):438-46. PubMed ID: 1678011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
